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THE purpose of this communication is to present an analysis of the age and
sex distribution ofa consecutive group of 67 osteogenic sarcomata, and to compare
and supplement certain data with those obtainable from other published series.
The cases here reported are derived from the records of the Bristol Bone Tumour
Register (BTR), and represent all such tumours registered and classified during
the period 1946-1954. Relevant details of individual cases are given in Table I.
It is not proposed in this paper to examine in any detail such aspects of osteo-
genic sarcoma as precise site of origin, histo-morphology, grading and prognosis,
except where such may be germane to the general argument. It is, however,
intended to present in the near future a further supplementary paper dealing with
these several factors in full detail.
Firstly however, it is essential to emphasize that there are certain peculiar
differences between bone sarcomata in juveniles and in older subjects. Hence it
is expedient to sub-divide the material for analysis into three groups of cases
according to age at time of onset:
1. Juvenile Group: Aged 0-34 years (31 cases-46 per cent).
2. Intermediate Group: Aged 35-49 years (7 cases-11 per cent).
3. Senile Group: Aged 50 years and over (29 cases-43 per cent).
Theintermediate agegroupislesswelldefinedthantheothertwo, andrelatively
few in number. Thus it cannot profitably be considered in detail, and admits only
the certain conclusion that bone sarcoma is rare during this middle period of life.
Anatomical Site Distribution of Present Series.
This is indicated in Table II, and mainly confirms the findings of other well
known and larger groups of cases.
Age Incidence of Complete Series.
The crude age distribution curve of the total Bone Tumour Register (BTR)
series is plotted in Fig. 1. The shape of this curve is characteristic of osteogenic
sarcoma and shows a marked juvenile increase in the second decade, and also a
smaller senile peak in the sixth decade. These features have given rise to the
generally accepted mis-statement regarding the age of maximum incidence of
osteogenic sarcoma. In the total number of cases seen it is true that the second
decade produces the most; but when such total numbers are adjusted for popula-
tion/age distribution it may then readily be seen that the incidence ofthis growth
is high for the adolescent period, with a marked fall in the succeeding years. TheTABLE I.
Initials. Age. Sex.
K. S. . 18 M.
P.C. .5 .M.
N. G. 13 . M.
N. J. 14 . F.
S. H.. 19. F.
D. C. . 21 M.
F. P. .42. F.
J. C. 20 M.
R. D. . 19 M.
G. C. 67 M.
A. L. . 58 . M.
R. K. 22 . M.
G. J. 73 . M.
E.M.J.. 73 F.
F. T. .38. F.
F.A.H.. 70 . F.
J. W. 27 M.
Y. M.. 24. F.
J.H. . 9 . M.
K. W. . 26 M.
A. G. 71 . M.
D.J.A.. 27 . M.
D. R. . 13 . M.
M.S.A.. 62 . F
J. S. 38 M.
W. G. . 73 M.
S. C. . 10 . F.
R. M.. 62. F.
E. C. 16 M.
M. C. . 14 M.
A. O. .64. F.
C. H. . 86 M.
M. G.. 14 .M..
T. H. . 15 M.
F. B. 67 . M.
C. P. .89. M.
J. B. .36. F.
A. D. . 60 . M.
A. H. . 66 M.
R. H. . 31 M.
W. M. 69 M.
M. B. .23 .F.
R. G. .82. F.
H. H.. 55. F.
J. B. .60 .M.
D. M. .49 F.
E. H. . 51 . M.
A. H. . 76 . F.
J. R. . 75 . M.
E. W. 45 . F.
A. D. .59. F.
F. F. .72. M.
A. R. .80 .F.
J. C. . 20 M.
A. F. .53. F.
E. M. . 59 M.
M. T. .13 .M.
R. L. . 49 A.
J. W. . 21 F.
D.R. . 8 . M.
M. S. 19 M.
D. M.. 18 . F
E. E. .57. F.
B.S. .9 .F.
J. S. 67 . F.
A. M. . 10 . F.
W. P. . 13 . F.
Site.
Femur
Humerus
Femur
Ilium
Tibia
99
Femur
Ilium
Humerus
Mandible
Tibia
Femur
Maxilla
Femur
Vertebra
Femur
Ilium
Femur
,,
Ilium
Femur
Humerus
Calvarium
Femur
,,
Vertebra
Femur
Humerus
Radius
Femur
Humerus
Femur
Humerus
Scapula
Femur
Femur
Femur
Femur
Femur
Femur
Femur
Tibia
Femur
Femur
Ilium
Femur
Humerus
Tibia
Tibia
Femur
Femur
Rib
Femur
Humerus
Femriur
Femur
Femur
Tibia
Tibia
Humerus
B
Type.
B.
B
B
B
B
B
L
B
B
L
B
B
B
B
B
B
L
B
B.
B
L
B
B
L
B
B
B
L
B
B
B
L
L
B
L
L
L
L
B
B/C
L
L
B
L
L
L
L
L
L
L
L
B/C
L
L
L
B/C
L
L
B
L
L
B
L
B/C
L
B
B
[istological Concomitant skeletal
Grade. disease.
II
II
I
II
II
II
II
III
III
III
II
III
III
II
II
III
III
III
III
III
III
III
II
III
II
II
III
III
III
III
III
II
III
II
II
II
II
II
II
III
II
II
III
II
III
III
II
III
III
II
II
III
III
II
II
II
II
I
II
Ir
II
II
II
Preceded by osteoclastoma.
Advanced Paget's disease.
Advaneed Paget's disease.
Fibrous displasia.
Advanced Paget's disease.
Early Paget's disease.
Advanced Paget's disease.
Advanced Paget's disease.
?preceded byenchondroma.
Paget's
Advanced Paget's disease.
Advanced Paget's disease.
Advanced Paget's disease.
Advanced Paget's disease..
Advanced Paget's disease.
Advanced Paget's disease.
Early Paget's disease.
Advanced Paget's disease.
B = Osteoblastic Osteogenic Sarcoma.
L = Osteolytic Osteogenic Sarcoma.
B/C = Chondrogenic Osteogenic Sarcoma. A type with unusually large chondroid element in
matrix.
Note.-Histological grading based upon author's method (Price, 1952).
No.
6
10
26
.35
39
43
44
61
66
67
70
*81
83
94
96
102
106
136
143
145
155
15,
163
169
191
198
.203
.212
213
221
226
230
250
273
299
317
337
338
406
414
416
423
428
440
450
-465
504
512
516
522
529
538
572
579
586
588
590
592
595
664
675
691
705
737
741
752
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TABLE II.
Anatomical Site. Number. Per cent.
Femur . . . 35 52- 2
Humerus . . . 11 16-4
Tibia . . 8 . 11*9
Ilium . . 5 . 7 5
Vertebra . . . 2 . 3
Skull . . . 2 . 30
Rib . 1 . 1-5
Radius . . . 1 . 1 5
Mandible . . . 1 1.5
Scapula . . . 1 1 5
incidence then rises rapidly during the fifth decade, and over the whole life span
reaches its maximum in the 7th and 8th decades (Fig. 2, 3 and 7).
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FIa. 1.-BTR Series. Crude age distribution.
It may immediately be suggested that the number of cases collected in the
BTR records in the decade 15-24 years is unduly low, owing to the absence of
young men on National Service with H.M. Forces during their 18th-20th years.
A correction for this can be made by reference to Table A2 in the Registrar
General's (1953) Statistical Review of England and Wales for the year 1952 (mid-
year). The difference between the statistics given for the total home population
and civilian populations (male) in the ages 15-24 years is 392,000, i.e. 14 per cent
ofall the males in this decade, or about 70 per cent ofall males ofage 18-20 years.
This difference of course represents young men who are actually called up and
posted. This figure has been checked by reference to the Regional Office of the
Ministry of Labour and National Service which supplied the information that the
proportion ofthose liable for national service who were either rejected or deferred
was on average 34 per cent for men born in the years 1929-32. On correction
therefore of the BTR series by plus 70 per cent of male sarcomata arising in the
age period 18-20 years, a total relative tumour incidence figure of 1-72 is obtained
for the second decade. This is still considerably lower than the comparable
figures of 2 1 and 1-9 respectively for the 7th and 8th decades. This calculated
figure (which is probably maximal) has been indicated as the separate point P in
Fig. 2. In the case of women, the number actually involved in national service is
too small to be of any significance.
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In the BTR series, the tumour incidence in the later decades exceeds that of the
2nd, and the curve shows that in the 9th decade, the overall tumour incidence
still remains high (Fig. 2). The corrected figures for age incidence of the BTR
series, and for the further series of osteogenic sarcomata reported by the British
Empire Cancer Campaing (1949), are separately plotted in Fig. 2, and it is interest-
ing to note their close agreement.
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FIG. 2.-Corrected age incidence curves for:
BTR series of 67 osteogenic sarcomata. * 0
BECC (1949) series of 73 osteogenic sarcomata. x . . . . X . . . . X
(All cases in each series, M + F.) The isolated point P indicates the calculated male figure,
aftermakingdue allowance formenaged 18-20years absent fromtheS.W. Region on National
Service.
Fig. 3 showsthe corrected ageincidence curveforthecombined BTR andBritish
Empire Cancer Campaign (BECC) series of 140 sarcomata. This may be compared
with a sinmilarly corrected curve for the series of 308 osteogenic sarcomata pub-
lished by Geschickter and Copeland (1949), in their Tables 17, 18, 21 and 22. The
typical juvenile peak again appears in the American series, but the marked senile
rise in incidence is absent.
The British series have been corrected for population age distribution
by applying the 5 years' mean derived from Table A4, 1948-52, S.W.
England and Greater London; whilst the American series have been
likewise adjusted by the mean 1930.and 1940 age distribution of the total
population ofthe United States. (Table II, p. 872, Vital Statistics Rates in
the United States, 1943). Comparison of these two sets of statistics shows
that in the age period over 45 years there was a significantly higher propor-
tion of persons in England and Wales than in the U.S.A., (9.2 per cent
difference.) The respective figures given for proportion of total population
in region over 45 years of age were:
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England and Wales
S.W. region plus Greater London, (1948 -52). 33.9%.
United States ofAmerica
Total population, (1930/40) . . . . . . 24.7%
Due allowancehasbeen madeforthisdifference in calcuating therelative
tumour incidence figures, both here and elsewhere. These figures are in
each instance based upon the following factor:
Per cent of tumours in series occurring in decade.
Per cent of relevant population in same decade.
This is abbreviated in the tables to %T. %P.
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FIG. 3. Corrected age incidence of combined group of 140 osteogenic sarcomata:
(BTR 67 + BECC 73), 0.
Corrected age incidence of 308 osteogenic sarcomata:
"(From Tables 17, 18, 21 and 22, Geschickter and Copeland, 1949), x- - -X- -x.
This remarkable apparent difference in incidence of osteogenic sarcoma in the
senior decades (Fig. 3) mayin somepart be due to the more complete differentiation
of secondary chondrosarcoma as a tumour entity by Geschickter and Copeland
(1949), who mention its predilection for patients ofthe age group 30-50 years, and
assess its frequency as being about equal to that of primary chondrosarcoma.
Moreover, they state that secondary chondrosarcoma is, in their experience, the
commonest form of bone sarcoma complicating Paget's disease. In the BTR
:series, however, by far the most frequent variant seen in Paget's sarcoma has been
the osteolytic osteogenic type-mostoften ofspheroidal orspindle cellmorphology.
Even those histologists experienced inthe diagnosis ofbone sarcomata occasionally
have difficulty in the differentiation of chondrosarcoma and certain osteogenic
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sarcomata, in which there may be a high proportion ofextracellular matrix. This
is rendered still more uncertain by the typically broad spectrum of mesenchymal
elements found in the latter tumour, and by indecision regarding the essentially
chondroid or osteoid nature of the ill-formed stroma.
In support ofthe American series of Geschickter and Copeland (1949), entirely
similar features obtain in the crude age distribution curve of Christensen (1925)
see Fig. 4, and in the tables published by Coley (1949). Both these latter series
show the typical marked juvenile peak incidence in the 2nd decade, but the later
big rise amongst older persons shown in the British series is absent. In the series of
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FIG. 4.-Age distribution of osteogenic sarcoma. (After Christensen, 1925.)
* * * Females, 150; *- * * Males, 226.
Geschickter and Copeland (1949), even after allowing for the difference in popula-
tion age distribution, osteogenic sarcoma is still three times as common amongst
youngpersons ofage 5-24 years, as it isinthe age group 55-74years. Inthe British
series (combined) this feature is reversed by a factor of 4 juvenile to 5 in the senile
group.
It must be pointed out here that in any analysis of a series of cases of a given
disease fallacies may arise due to the manner in which the material has been
collected, and the available sources of such. The BTR series of 67 osteogenic
sarcomata has been compiled upon ageographical rather than upon an institutional
basis. The comparison ofthe numbers included in this with contemporary records,
furnished by the Records Officer of the S.W. Region Cancer Records Bureau
(Bristol) (1955, personal communication), indicates that the BTR cases repre-
sent about 75 per cent ofthe cases reported to him. Of the 67 patients 51 dwelt.
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in the Bath/Bristol area, whilst the remaining 16 were referred from Exeter (5),
Salisbury (4), Bedford (2), Northampton (2), Gloucester, Coventry and Kent,
1 case each. The whole BTR group may therefore be regarded as being fairly
representative of the incidence and distribution of this form of bone sarcoma
amongst a well assorted sample of the population of the United Kinadom. By
contrast, the BECC series of cases are derived from many sources, and are hence
probably an entirely random sample, but devoid of any institutional bias.
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FIG. 5.-Corrected age incidence curve for group of 117 primary chondrosarcomata.
(Geschickter and Copeland, 1949, Tables 9 and 10.)
Curve for 74 males, 0p 0
Curve for 43 females, x x- - ---x-
Examination of the corrected age incidence curve for the closely allied tumour
primary chondrosarcoma (data from Tables 9 and 10, Geschickter and Copeland,
1949), shows again a similar single peak of maximum age incidence in the 2nd
decade (Fig. 5). Fig. 6 shows the corrected age incidence curves of two series of
soft tissue fibrosarcomata. (British Empire Cancer Campaign, 1949; Stout, 1948).
Also plotted in Fig. 6 is the corrected age incidence curve of one series of 97
lymphosarcomata (British Empire Cancer Campaign, 1949.) Broadly, these three
curves all show anirregular but continued risein sarcomaincidence withadvancing
age up to the 8th decade, with no sign ofthe well defined and distinct 2nd decade
juvenile peak so characteristic of primary skeletal sarcomata.
From this comparison then one may conclude that in the causative mechanism
ofbone sarcoma there is a strongly acting aetiological factor which is present in the
age period 5-24 years, and again in the British series throughout the later decades,
although this is not confirmed by the American data.
Analysis of the Sex Incidence
The crude sex distribution figures of both the BTR and BECC series of osteo-
genic sarcomata are given in Tables III and IV.
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FIG. 6.-Corrected age incidence curves for:
Group of 200 fibrosarcomata (Stout, 1948), *
Group of 71 fibrosarcomata (BECC series, 1949), x- - - - - - - x.
Group of 97 Lymphosarcomata (BECC series 1949), Q. ..
TABLE III.
Total Male,s. Females.
BTR series . 67 39 28
BECC series 73 41 32
Combined Totals 140 80(57%) 60(43%)
In a total of 308 osteogenic sarcomata, Geschickter and Copeland (1949)
recorded 59 per cent males and 41 per cent females. The crude sex/age distribution
of the combined British series are given in Table IV. Fig. 7 shows the relative
TABLE IV.
Years. Total.
0-. 5-. 15-. 25-. 35-. 40-. 45-. 50-. 55-. 60-. 65-. 70-. 75-. 80-. 85-.
Male. 1 13 19* 8 1 1 3 4 5 9 6 5 2 1 2 .80
Female 11 8 3 2 4 5 3 6 5 4 5 2 2 .60
fM.=F- 1-2 2-4 2*7 0*5 0 3 0*6 1-3 0.8 1.8 1*5 1.0 1*0 0*5 1-3 F.
* Inviewof the male absence on national service at age 18-20 years, thecrudefiguremight be as
high as 22 sarcomata, which would then give a sex factor (F) of 2- 8 in this decade.
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tumour incidence for men and women after correction of the crude figures of
Table IV for sex and age distribution of the home population.
From consideration ofthe combined British data, the following points appear:
(i) The juvenile female peak incidence occurs at a slightly earlier age than in
the male (Fig. 7).
(ii) In both sexes alike, the incidence of osteogenic sarcoma is low during the
intermediate age period, 30-45 years, whenthere also appears reversal ofthe other-
wise usual male predominance.
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FIG. 7.-Relative incidence of osteogenic sarcoma.
Population corrected curves for: 80 males 0 0 *. 60 females
x . . . . x . . . . X. Combined BTR and BECC series of 140 cases.
(iii) After adjusting for differences in age and sex of the home population
distribution, the figures shown in Table V are obtained for the corrected sex ratios.
(iv) Consideration of the juvenile age group (0-34 years) in greater detail in
Table IV shows that in the combined BTR and BECC series of cases the female
maximum tumour incidence appears in the age period 5-14 years, whilst in the
male it occurs in the succeeding decade. This feature is absent on detailed
analysis of the 213 sarcomata under 35 years of age recorded by Geschickter and
Copeland (1949, Tables 17, 18, 21 and 22). On treating this American juvenile
group as a complete series, both from the viewpoints of age and sex distribution,
the following values were calculated for relative tumour incidence as set out in
Table VI and Fig. 8.
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TABLE V.
Age Groups.
Jtivenile. Intermediate. Senile.
All Cases. 0-34 35-49. 50+.
140 . 63 16 61
Males:
Total sarcomata . . 80 . 41 5 34
Females:
Total sarcomata . . 60 . 22 11 27
Males:
% sarcomata in age group . 57 . 65 31 56 -
Females: - 100
Ditto . . . 43 . 35 69 44J
Males:
% Population in age group . 46-1 . 48 50 5 461
Females: - 100%
Ditto . . . . 53.9 . 52 49.5 54J
Tumnour Incidence
Male %p . 1-24 . 1.36 0 67 1.22
Female %p . . . 0 8 . 0-67 1-39 0X81
Corrected Sex Factor:
T. Incidence Male 1.55 2-0 0*48 1.54
T. Incidence Female
TABLE VI.
Age Group
Under 5 yrs. 5-14 yrs. 15-24 yrs. 25-34 yrs.
Males:
% Tumours in series . 21-8 59 7 18-5
% Population in age group. 13- 8 29-1 30 3 26 8
Tumour Incidence:
Males . . . - 0 75 1-96 0-69
Females:
% Tumours in series . 32- 5 55.1 12-7
% Population in age group. 129 28- 2 30 7 28-2
Tumour Incidence:
%/T. Females . . . 1.15 1-79 0-45
/0
In this table the high relative incidence figure for females of the age period
5-14 years is noteworthy.
Discussion. Juvenile Group.
The typical site oforigin ofosteogenic sarcoma in the young growing long bone
is well known, and there are good reasons to relate this site frequency to an
aberration of metaphyseal bone growth. Since this component contributes solely
to length growth inlong bones, it now becomes pertinent to inquire to whatextent
the known differences in skeletal development in the two sexes may be correlated
with the following features:
1. The marked male preponderance of osteogenic sarcoma in juveniles.
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2. The relatively earlier period of the female maximum tumour incidence, as
shown by the combined British series of cases, and the greater relative incidence
of this tumour in girls of age 5-14 years, as shown by both British and American
data.
In this respect, total height of the individual can be taken as a useful index of
skeletal length growth, the outstanding contribution to which is the growth which
takes place at the lower end ofthe femur and upper end ofthe tibia. By combining
the figures ofdifferential epiphyseal growth in humans ofDigby (1916), with those
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FIG. 8.-Corrected age incidence curve for group of 213 sarcomata (osteogenic).
Males (124), 0 0 *. Females (89), x--- --- x - -x. From Tables
17, 18, 21 and 22; Geschicketer and Copeland, (1949). All cases under 35 years of age.
statedfor per cent contributions offemur and tibia to totalheight ofthe individual
byGillandAbbott (1942) it ispossible to calculate thatthedistalfemoralandproxi-
mal growth constitute respectively 20 and 12 per cent of the total height, out of
an overall component of 51 per cent of height attributed to the leg.
In the human species, neither growth in height nor in weight progress evenly.
It has long been known that child growth may be roughly divided in both sexes
into three " springing-up " and three " filling-out " periods. These are depicted
in the curves in Fig. 9, (after Stratz), and may be further given approximately in
Table VII.
TABLE VII.-" Springing-up " and " Filling-out " Periods in Males and Females.
1st. S.U.P. 1st. F.O.P. 2nd. S.U.P. 2nd. F.O.P. 3rd. S.U.P. 3rd. F.O.P.
(yrs.) (yrs.) (yrs.) (yrs.) (yrs.) (yrs)
Male . . 1-2 3-5 . 6-7 . 8-12 13-15 . 16-20
Female . 1st. . 2-5 . 6-7 . 7-9 . 9-12 . 13-20
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On attempting to fit the springing-up periods ofmost active bone growth to the
known incidence of osteogenic sarcoma it is unlikely that the 1st springing-up
period has much bearing, in view ofthe extreme rarity ofbone sarcoma under the
age of 5 years (0.7 per cent of present combined series).
Complete data are unfortunately scanty, but in the four years following the
2nd springing-up period (i.e. age 7-10 years, inclusive), in the combined figures of
the BTR series and those of Geschickter and Copeland (1949), there appears in
males 6-3 per cent, and in females 12 per cent ofa total of242 osteogenic sarcomata
under 35 years of age. At this period the difference between male and female
populations is under 1 per cent, both for Britain and the U.S.A. The total number
of cases is very small, but here, again, the reversed sex incidence agrees withthat
. First Second Second Third Third
L. filling-out spr-ing-up filling-out springing-up filling-out
Year 1 2 3 5 6 7 8 9 10 11|12|13|14 15 16 17 18 19 20
180-
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120j-j 6
100- _ Z_50
60g; /30
40 - '-20
20 _10
0 0
FiG. 9.-The growth curve according to Stratz, Boys *Girls- - - -, from
' Bone Growth in Health and Disease ', by H. A. Harris. (p. 90).
noted above for the wider age period of 5-14 years ,(Table VII). This suggests
that even at this very young age the difference in tumour incidence between the
sexes is due to the relatively advanced bone growth in girls, which has been
estimated to be, on average, 1 year in front of boys at chronological age 9 years
(Todd, 1937). This difference in bone age is thought to increase to as much as 2 or 3
years on attaining chronological age 12 years. It should however be added that
the 1st and 2ndgrowth spurts are not so welldefinedgenerally, orin theindividual,
as the 3rd-the so-called " adolescent growth spurt ".
This adolescent acceleration of bone length growthis characteristic ofman and
primates, and is said not to take place in other mammals. Its earlier onset in girls
is now well established as occurring at age 9-12 years, the data reported by
Simmons and Greulich (1943) andSimmons (1944) confirming the earlier findings of
Shuttleworth (1938). In boys this adolescent growth spurt takes place at 12-14
years ofage. These figuresagree wellwith theposition ofmaximumgradient in the
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curves shown in Fig. 9. The data published by Schwerz (1928), quoted by Gill and
Abbott (1942), also shows that this increased rate of growth in girls precedes
that of boysfor the individual long bone (e.g. femur and tibia) by 1 to 2 years, but
with some quantitative variation between different bones.
The data compiled by various workers have indicated that, in girls, the time of
onset of the adolescent growth spurt is closely related to the time of appearance
of the menarche and onset of puberty; furthermore, it has been noted by Stone
and Barker (1937) that the hypofeminoid type of girl has a late menarche and
delayed adolescent growth spurt, although this latter may be eventually prolonged
to lead to greater than average height, so resembling more closely the male growth
pattern. Itis clear, ofcourse, bothin Europeans andAmericans, thatthe adolescent
growth spurt of boys, though later than that of girls by about 2 to 3 years, on
average produces greater male height. In both sexes, however, this measurement
is influenced also by parental stature (Harris et al., 1930).
In the light ofthese anthropometric findings, then, it is here suggested that the
earlierincreasedrelativeincidence ofosteogenic sarcoma in young girls isduetothe
earlier age ofoccurrence ofthe adolescent growth spurt. The greater total tumour
incidence in the young male is due to the relatively increased length growth ofthe
skeleton, i.e. bothtime and tissue bulk factors being unduly weightedinfavourofa
greater male " risk ".
This latter explanation is strongly supported by the high sarcoma incidence in
the lower end of the femur, where length growth is maximal, and its relative
rarityin the short tubular bones ofhand andfoot. Whilst the latter grow in length
from a single terminal epiphyseal plate, the absolute linear growth in centimetres
for each bone is much less than that of the femur shaft and other major appendi-
cular long bones.
The Senile Age Grcup (Over 50 Years).
Age distribution-all cases in combined BTR and BECC series (Table IV).
Although the uncorrected age distribution curve in Fig. 1 shows maximum
tumour incidence in the 7th decade, the corrected age incidence curve for the BTR
series indicates that there may possibly be a further rise in the age period 85-94
years. This feature would resemble the general tread of fibrosarcoma (Fig. 6),
but the number of cases encountered at this advanced age is too small to permit
any definite conclusion upon this point.
Incidence of Paget's osteitis deformans.
The separate and combined totals of cases associated with Paget's disease of
bone are shown in Table VIII.
TABLE VIII.-steogenic Sarcomata associated with Paget's disease.
Males. Females.
_ -A
50. 60-. 70-. 80-. Total. 50-. 60,. 70-. 80,. Total.
BTR . 2 3 4 1. 10 . 4 2 2 1. 9
BECC . . . 6 . . 7
Combined . 16 . 16
Incidence in total cases in age group (34) . . 47% . Incidence in total cases in
age group (27) . . 59%
Incidence in combined series of 61 sarcomata (over 50 yrs.) . . . . . . 52*4%
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This table shows the approximately equal sex distribution of Paget's disease
in cases of osteogenic sarcoma over 50 years of age, the condition being well
advanced and active in about one half of the senile bone sarcomata encountered.
On correcting these crude figures for the sex distribution of persons over 50 years
(Males 46 per cent, Females 54per cent), the totals in Table VIII would be modified
to give: males, 16 sarcomata; females, 14 sarcomata. There is again here a small
relative male preponderance.
During examination of the BTR collection of specimens, evidence has been
found suggesting extra-osseous connective tissue changes in Paget's disease. In
one case (BTR/510, male aged 52) well advanced Paget's disease was associated
with a soft tissue parosteal fibrosarcoma of the leg. Furthermore, although in the
BTR juvenile group osteoblastic osteogenic sarcoma was seen three times as often
as the osteolytic form, in the senile group this factor is reversed, the latter tumour
being about three times as common.
Site analysis of the BTR series of sarcomata associated with Paget's disease
fully confirms the point emphasized by Davie and Cooke (1937) that such growths
are not infrequently multicentric in origin, and arise in the bone damaged by the
osteitic process. Therefore, in general terms, the anatomical site distribution of
the senile form of this sarcoma runs largely parallel with the skeletal distribution
ofPaget's disease, i.e. related to bone which is ofmembranous or periosteal origin,
and with a relatively high site frequency in flat bones.
Senile osteogenic sarcoma not related to Paget's disease.
Two features have been noted in these cases:
A. Very occasionally there is evidence which suggests that the sarcoma is
secondary to a pre-existing benign tumour, e.g. BTR/67, G. C.- male, aged 67;
giant cell tumour oflower end offemur. BTR/230, C. H- male, aged 86; enchon-
droma of diaphysis of femur.
B. In some instances, particularly in femoral lesions, there has been radio-
graphic and histological evidence of advanced osteoporosis. Histologically, as age
advances, bone structure becomes more clearly defined, and both analytical and
histochemical methods have shown tissue dehydration and relative loss of the
mucopolysaccharide component of cartilage and inter-fibre cement substance.
Histological examination of bone structure in the immediate vicinity of a number
of senile osteogenic sarcomata, however, suggests that the continuation of this
osteoporotic process may eventually lead to very extensive bone destruction via
demineralization and disorganisation of the organic framework. Consequent
vicarious formation of much new osteoid is also seen.
Sex distribution.
The sex distribution and relative tumour incidence for the combined BTR and
BECC cases over 50 years of age are given in Table IX.
Examination of the combined BTR and BECC figures for cases over 50 years
of age shows a crude sex ratio, (M/F.), of f. = 1-26, i.e. 5 males to 4 females. On
correction, however, forpopulationsexdistribution, this ratioincreasestof. = 154
i.e. 3 males to 2 females. This factor then approaches that found in the juvenile
group, where f. - 2-0 (Table V). This male preponderance appears possibly to be
reversed in the age period 50-60 years (f. = 0 75), and to be lower still in the
preceding intermediate age group of 35-49 years, where f. = 0-48 (Table X).
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TABLE IX.
Age.
Males. 50-. 60-. 70-. 80-. Total.
Total tumours . . . 9 1.5 7 3 . 34
% Tumours . 26 44 21 9 . 56
°/ Population in age group . 44-8 33-4 17-6 4-2 46
Tumour incidence 0° . . 0 6 13 12 2- 1l22
Females.
Total tumours . . . 9 9 7 2 . 27
% Tumours . 33 33 26 8 . 44
%Population in age group . 40-8 329 20 5 5-8 . 54
% T.1214 0 Tumour incidence % . 0-8 10 1-26 1-4 0-8
Sex Factor, corrected
to f _ T.incidence,M. 1-3 0 95 1a . 1-54 T. incidence, F.
Note.-Per cent of tumours in each decade calculated upon basis of total tumours, (M. or F.) over
50 years = 100.
Per cent of population in each decade based upon proportions of male and, female population in
decade, of all persons over 50 years of age.
Totals in last column calculated from ratio:
Per cent tumours male (or female) over 50 years.
Per cent population male (or female) over 50 years.
TABLE X.-Intermediate Age Group-35-49 years.
Intermediate Age
Group 35-49 years.
Males.
Total tumours in period . . 5
% Total tumours in period . 31*2%
% Total population in age period 50*5%
Tumour incidence. . 0 67
Females.
Total Tumours in period 11
% Total tumours in period 68- 8%
% Total population in age period 49-5%
Tumour incidence. p . . 1-4
Corrected Sex Factor.
T. incidence, male.
T. incidence, female. 0 48
The inference from these figures is that the factor or factors which cause the
relative male preponderance ofosteogenic sarcomata in juveniles, are still operative
in the senile group. It has already been suggested that this male frequency is
related to the overall greater bone length growth of men, which feature may also
basically influence the increased male incidence of Paget's disease in like manner.
The data ofTable VIII would support this assertion, but are not conclusive, since
even after correcting for the population sex distribution at this age, the male
relative increase is only very small. As in the juvenile group, so here also, there is
some suggestion from the corrected age/sex distribution curve (Fig. 7) that the
incidence of osteogenic sarcoma in later years rises somewhat more rapidly for
women.
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Discussion-senile group of ca83es.
On comparison, the sex incidence differences noted in senile cases ofosteogenic
sarcomata are absent in the groups of fibrosarcomata and lymphosarcomata of
similar age ofthe several series considered above. In the BECC 1949 series of both
of these latter tumours, the corrected'sex factor (M./F) in respect ofpatients over
45 years of age was found to be 0-85 for lymphosarcoma and 1-05 for fibrosarcoma.
InDthe larger Amierican series offibrosarcomata ofStout (1948) no details are given
for the age/sex distribution; it was however stated that the total group included
100 men and 106 women.
(Note.-Although lymphosarcoma usually shows a well marked male preponde-
rance when all ages are combined, the BECC 1949 series records 34 males and 31
females over 45 years ofage. OnDapplying to thesefigures theappropriate correction
for sex distribution in the population over 45 years, the ratio
Tumour incidence, male -08. Tumour incidence, female -08.
These differences suggest that assumingr the causative mechanism of these
three forms of sarcoma to be of a similar nature, in the case ofosteogenic sarcoma
the relative frequency in persons over 50 years of age is markedly influenced by
some added factor which is sex hormone dependant.
SUMMARY AND CONCLUSIONS.
1. A series of 67 osteogenic sarcomata has been analysed for the factors of age
and sex distribution and incidence. The resulting data have been supplemented
by a further series of 73 osteogenic sarcomata reported by the British Empire
Cancer Campaign (1949). These figures have been compared and contrasted with
two American series, and also with groups of cases of primary chondrosarcoma,
lymphosarcoma and fibrosarcoma.
2. The data presented shows that the incidence of osteogenic sarcoma is
relatively higher amongst the population of England (S.W. Region) during, the
7th and 8th decades than in the 2nd decade, as is most generally believed. In
view of the small number of cases available in this series it is not clear as to the
relative incidence in the 9th decade, although there is some suggestion that this
may be still higher than in the two preceding periods. These latter features
resemble the late age incidence trends in soft tissue fibrosarcoma. This latter
tumour however does not show, in the series examined, the differential male
preference which is seen in osteogenic sarcoma, both juvenile and senile.
3. The sex incidence of the cases of the age period under 35 years has been
correlated with the know-n features of juvenile bone growth. It is suggested that
the sex incidence differences are due to the characteristically earlier development
of the female skeleton, and the greater total bone growth in length of the male.
4. The intermediate age group (35-49 years) provides too few cases for detailed
treatment, butindicatesthe comparative rarity ofbone sarcoma ofthistypeduring
this period of life. In the very small number of cases considered there is reversal
of the otherwise usual male predominance.
5. In the senile group (over 50 years) one half of all cases here reported were
associated with Paget's osteitis deformans. After correction for differences in
population age/sex distribution the male sex predominance is again found to be
about the same order as that encountered in the juvenile group.
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In addition to the original list of cases formerly studied by the author (1952),
further material has been included here from the following sources, all being cases
referred to the Bristol Bone Tumour Register:
J. Bastow, Esq., F.R.C.S. . Nos. 516, 705.
Dr. S. Curwen, D.M.R.T. No. 67.
A. L. Eyre-Brook, Esq., F.R.C.S. . Nos. 44, 450, 512, 754.
Dr. H. J. Gibson. . . Nos. 522, 572.
Dr. R. C. Hadden. Nos. 406, 414.
Dr. E. J. Harries. No. 595.
H. K. Lucas, Esq., F.R.C.S. Ed. . Nos. 416, 423, 440.
Dr. E. M. Martland No. 675.
W. R. Mitchell, Esq., F.R.C.S. . Nos. 691, 752.
J. A. Penrose, Esq., F.R.C.S. No. 664.
K. H. Pridie, Esq., F.R.C.S. Nos. 504, 538.
Dr. R. Sandry. . Nos. 737, 741.
J. B. Shield, Esq., F.R.C.S. Nos. 579, 590, 592.
Dr. G. Stewart Smith. . No. 586.
Dr. A. L. Taylor . Nos. 428, 529.
Dr. J. C. Valentine. Nos. 465, 588.
The author wishes to record his thanks to the surgeons, radiotherapists and
-pathologists who have referred these cases, and have rendered invaluable assistance
by the loan of clinical notes, skiagrams and pathological specimens. Thanks are
also due to Mr. A. E. S. Roberts of the Medical Library, University of Bristol, for
much help; also to Dr. H. A. Sissons for his helpful criticism of this paper.
Fig. 4 is reproduced by kind consent ofthe author and publishers ofthe Annals
ofSurgery; Fig. 9 has been copied by permission ofthe publishers. This courtesy
is also acknowledged with thanks.
This present work, together with that of the Bristol Bone Tumour Register,
has been generously aided by grants from the British Empire Cancer Campaign,
and from the Cancer Research Fund of the University of Bristol.
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